Bioequivalence Study without approved/marketed or no RLD [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-03-13 09:37 (1476 d 21:22 ago) – Posting: # 21261
Views: 3,597

Hello All,

Greetings!!

We got an inquiry to conduct BE for XYZ molecule but at the time of feasibility we came to know that RLD for XYZ molecule is not approved/marketed in our country. Means there is no RLD.

Still sponsor wants to market their product. In this case, what we can do? Can we do directly PK study or Phase III study of sponsor's product in patients?

Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
88 visitors (0 registered, 88 guests [including 11 identified bots]).
Forum time: 06:59 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5